参考文献/References:
[1] UHLIG T,MOE R H,KVIEN T K.The burden of disease in rheumatoid arthritis[J].Pharmacoeconomics,2014,32(9):841-851.
[2] KRONZER V L,DAVIS J M.Etiologies of rheumatoid arthritis:update on mucosal,genetic,and cellular pathogenesis[J].Curr Rheumatol Rep,2021,23(4):21.
[3] OHGI K,KAJIYA H,GOTO-T K,et al.Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1[J].Lipids Health Dis,2018,17(1):132.
[4] 苏雨荷,王刚,文振华,等.类风湿关节炎的发病机制及药物治疗研究进展[J].西北药学杂志,2021,36(5):857-861.SU Y H,WANG G,WEN Z H,et al.Research progress on the pathogensis and drug treatment of rheumatoid arthritis[J].J Northwest Pharm,2021,36(5):857-861.
[5] 祁芳,李艳玲,艾坤,等.SD大鼠佐剂性关节炎模型的建立与评估[J].湖南中医药大学学报,2016,36(1):23-26.QI F,LI Y L,AI K,et al.The establishment and evaluation of adjuvant-induced arthritis in SD rats[J].J Hunan Univ Chin Med,2016,36(1):23-26.
[6] 孙爱静,徐先祥,黄晓东,等.七叶莲花抗炎镇痛作用及机制研究[J].中药材,2014,37(2):311-315.SUN A J,XU X X,HUANG X D,et al.Studies on the anti-infla-mmatory and analgesic effects of Schefflera arboricola Hayata and its mechanism[J].J Chin Med Mater,2014,37(2):311-315.
[7] 林小凤,张慧,隋臻,等.七叶莲不同溶剂提取部分的抗炎镇痛作用[J].中国生化药物杂志,2012,33(4):346-349.LIN X F,ZHANG H,SUI Z,et al.Anti-inflammatory and analgesic activities of compounds isolated from the Schefflera arboricola Hayata with different solvents[J].Chin J Biochem Pharm,2012,33(4):346-349.
[8] KUMAR A,DHALIWAL N,DHALIWAL J,et al.Astaxanthin attenuates oxidative stress and inflammatory responses in complete Freund-adjuvant-induced arthritis in rats[J].Pharmacol Rep,2019,72(1):104-114.
[9] DARAM P,JITTA S R,SHREEDHARA C S,et al.Investigation of anti-inflammatory and anti-arthritic potentials of terminalia catappa bark using in vitro assays and carrageenan-induced inflammation,complete Freund′s adjuvant induced arthritis model in rats[J].S Afr J Bot,2021,141:313-321.
[10]中国医科院药用植物研究所.中药学[M].北京:人民卫生出版社,1994:561-565.INSTITUTE OF MEDICINAL PLANTS,CHINESE ACADEMY OF MEDICAL SCIENCES.Science of Chinese pharmacology[M].Beijing:People′s Medical Publishing House,1994:561-565.
[11] 刘同祥,张艳萍.七叶莲的研究进展[J].中央民族大学学报(自然科学版),2010,19(2):75-77.LIU T X,ZHANG Y P.Research progress on Schefflera arboricola root[J].J Minzu Univ China (Nat Sci Edit),2010,19(2):75-77.
[12] 杨海波.疏风胜湿汤联合吲哚美辛治疗类风湿性关节炎随机平行对照研究[J].实用中医内科杂志,2015,29(1):95-97.YANG H B.Expelling wind and dampness decoction combined with indomethacin random parallel controlled study on treatment of rheumatoid arthritis[J].J Pract Trad Chin Int Med,2015,29(1):95-97.
[13] 廖婉婷,潘文疆,蔡聪艺,等.七叶莲对佐剂性关节炎大鼠的治疗作用[J].海峡药学,2018,22(6):25-27.LIAO W T,PAN W J,CAI C Y,et al.Therapeutic effect of Paris polyphylla Simth in Freund′s complete adjuvant arthritis rats[J].Strait Pharm J,2018,22(6):25-27.
[14] 杨渐,张晓昕,刘倩,等.钩吻素子对佐剂诱导关节炎大鼠T辅助细胞因子平衡偏移的调节作用[J].中国药理学与毒理学杂志,2018,32(9):719-725.YANG J,ZHANG X X,LIU Q,et al.Regulation of Koumine on the balance shift of T helper cytokines in rats with adjuvant-induced arthritis[J].Chin J Pharmacol Toxicol,2018,32(9):719-725.
[15] DONG C,FU T,JI J,et al.The role of interleukin-4 in rheumatic diseases[J].Clin Exp Pharmacol Physiol,2018,45(8):747-754.
[16] 李伟,王佳怡,肖春媛,等.IL-4通过促进CD30分子表达抑制类风湿关节炎患者T细胞功能的研究[J].同济大学学报(医学版),2021,42(4):528-533.LI W,WANG J Y,XIAO C Y,et al.IL-4 inhibits T cell function in patients with rheumatoid arthritis through promoting CD30 expression[J].J Tongji Univ (Med Sci),2021,42(4):528-533.
[17] SUN Y H,WEI S T,ZONG S H,et al.Correlation between IL-4 gene polymorphismas well as its mRNA expression and rheumatoid arthritis[J].Eur Rev Med Pharmacol Sci,2017,21(17):3879-3885.
[18] TAKASUGI K,YAMA M,IWAHASHI M,et al.Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis[J].Arthritis Res Ther,2006,8(4):R126.
[19] JOHNSON J L,JONES M B,COBB B A,et al.Polysaccharide-experienced effector T cells induce IL-10 in FoxP3+ regulatory T cells to prevent pulmonary inflammation[J].Glycobiology,2018,28(1):50-58.
[20] 周惠敏,胡志刚.白细胞介素-10抑制类风湿关节炎患者的研究进展[J].医疗装备,2019,32(23):197-199.ZHOU H M,HU Z G.Research progress of interleukin-10 inhibition in patients with rheumatoid arthritis[J].Med Equipm,2019,32(23):197-199.
[21] BJARNADTTIR U,EINARSDTTIR H K,STEFNSDTTIR E,et al.Resolution of Th/Tc17-driven inflammation during anti-TNFα treatment of rheumatoid arthritis reveals a unique immune biomarker profiling pattern[J].Scand J Immunol,2021,95(1):e13116.